Business Context and Reporting Period
This Form 8-K is a current report filed by Neuralstem, Inc. (not Palisade Bio, Inc.) on April 28, 2008. The filing reports a specific corporate event under Item 8.01 (Other Events) rather than providing periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory milestone and contains no financial statement data.
Material Changes
The material event reported is the granting of European Patent EP0915968 by the European Patent Office on April 28, 2008. This represents an expansion of the company's intellectual property portfolio in Europe.
Guidance, Outlook, and Risks
The filing includes a press release (Exhibit 99.1) regarding the patent grant but does not contain updated financial guidance, management commentary on future performance, or specific risk factors beyond standard regulatory disclaimers. The report explicitly states that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the scope and commercial applicability of European Patent EP0915968.
- Confirm the company name is Neuralstem, Inc., as the metadata reference to Palisade Bio, Inc. appears to be an error.
- Review the attached press release (Exhibit 99.1) for details on the patent's specific technology.
- Check subsequent filings for financial impact, as this 8-K contains no financial data.